Zobrazeno 1 - 10
of 613
pro vyhledávání: '"Marttila, R."'
Autor:
Marttila, R. (Riitta)
Respiratory distress syndrome, RDS, is a multifactorial lung disease of premature infants. The main cause of RDS is a deficiency of pulmonary surfactant, a lipoprotein mixture required to reduce surface tension at the air-liquid interface and to prev
Externí odkaz:
http://urn.fi/urn:isbn:9514272145
Autor:
Keskinen, E., Marttila, A., Marttila, R., Jones, P.B., Murray, G.K., Moilanen, K., Koivumaa-Honkanen, H., Mäki, P., Isohanni, M., Jääskeläinen, E., Miettunen, J.
Publikováno v:
In European Psychiatry September 2015 30(6):719-727
Autor:
Hallman, M. (Mikko), Ronkainen, E. (Eveliina), Saarela, T. V. (Timo V.), Marttila, R. H. (Riitta H.)
The present review considers some controversial management practices during extremely premature perinatal transition. We focus on perinatal prevention and treatment of respiratory distress syndrome (RDS) in immature infants. New concerns regarding an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::0e07cdd0d1677b792de840b9637ceaf5
http://urn.fi/urn:nbn:fi-fe2022091258340
http://urn.fi/urn:nbn:fi-fe2022091258340
Autor:
Määttä, A.-J. (Anni-Julia), Paananen, M. (Markus), Marttila, R. (Riikka), Auvinen, J. (Juha), Miettunen, J. (Jouko), Karppinen, J. (Jaro)
Introduction: Smoking and behavioral problems are related to musculoskeletal (MS) pain in adolescence. Maternal smoking during pregnancy (MSDP) is associated with offspring’s behavioral problems but its relation to MS pain in adolescence is unknown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::2d647e6b0faff1b81182ef21caa874e3
http://urn.fi/urn:nbn:fi-fe2019110837249
http://urn.fi/urn:nbn:fi-fe2019110837249
Autor:
Husa, A. P. (Anja P.), Moilanen, J. (Jani), Murray, G. K. (Graham K.), Marttila, R. (Riikka), Haapea, M. (Marianne), Rannikko, I. (Irina), Barnett, J. H. (Jennifer H.), Jones, P. B. (Peter B.), Isohanni, M. (Matti), Remes, A. M. (Anne M.), Koponen, H. (Hannu), Miettunen, J. (Jouko), Jääskeläinen, E. (Erika)
Publikováno v:
Psychiatry Research
Article
This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants with schizophrenia and 191 controls from the Nor
This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants with schizophrenia and 191 controls from the Nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a9422a86b20826317762e141a6511c36
http://hdl.handle.net/10138/205956
http://hdl.handle.net/10138/205956
Autor:
Oshukova, S. (Svetlana), Kaltiala-Heino, R. (Riittakerttu), Miettunen, J. (Jouko), Marttila, R. (Riikka), Aronen, E. T. (Eeva T.), Marttunen, M. (Mauri), Kaivosoja, M. (Matti), Lindberg, N. (Nina)
Background: Psychopathy research has thus far focused mostly on child, male, and delinquent samples, but the results are most likely non-generalizable to adolescent girls with mental health disorders. Aim: The present study aimed to compare self-rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::9fce55d193f5852c9ee37bacef4a5178
http://urn.fi/urn:nbn:fi-fe2019110837250
http://urn.fi/urn:nbn:fi-fe2019110837250
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hacke, Werner, Kaste, Markku, Bluhmki, Erich, Brozman, Miroslav, Dávalos, Antoni, Guidetti, Donata, Larrue, Vincent, Lees, Kennedy R., Medeghri, Zakaria, Machnig, Thomas, Schneider, Dietmar, Von Kummer, Rüdiger, Wahlgren, Nils, Toni, Danilo, Hacke, W, Dávalos, A, Kaste, M, von Kummer, R, Larrue, V, Toni, D, Wahlgren, N, Lees, Kr, Heiss, Wd, Lesaffre, E, Orgogozo, Jm, Bastianello, S, Wardlaw, Jm, Peyrieux, Jc, Sauce, C, Medeghri, Z, Mazenc, R, Machnig, T, Bluhmki, E, Aichner, F, Alf, C, Baumhackl, U, Brainin, M, Eggers, C, Gruber, F, Ladurner, G, Niederkorn, K, Noistering, G, Willeit, J, Vanhooren, G, Blecic, S, Bruneel, B, Caekebeke, J, Laloux, P, Simons, Pj, Thijs, V, Bar, M, Dvorakova, H, Vaclavik, D, Boysen, G, Andersen, G, Iversen, Hk, Traberg-Kristensen, B, Marttila, R, Sivenius, J, Trouillas, P, Amarenco, P, Bouillat, J, Ducrocq, X, Giroud, M, Jaillard, A, Larrieu, Jm, Leys, D, Magne, C, Mahagne, Mh, Milhaud, D, Sablot, D, Saudeau, D, Busse, O, Berrouschot, J, Faiss, Jh, Glahn, J, Görtler, M, Grau, A, Grond, M, Haberl, R, Hamann, G, Hennerici, M, Koch, H, Krauseneck, P, Marx, J, Meves, S, Meyding-Lamadé, U, Ringleb, P, Schneider, D, Schwarz, A, Sobesky, J, Urban, P, Karageorgiou, K, Komnos, A, Csányi, A, Csiba, L, Valikovics, A, Agnelli, G, Billo, G, Bovi, P, Comi, G, Gigli, G, Guidetti, D, Inzitari, D, Marcello, N, Marini, C, Orlandi, G, Pratesi, M, Rasura, M, Semplicini, A, Serrati, C, Tassinari, T, Brouwers, Pj, Stam, J, Naess, H, Indredavik, B, Kloster, R, Czlonkowska, A, Kuczyńska-Zardzewialy, A, Nyka, W, Opala, G, Romanowicz, S, Cunha, L, Correia, C, Cruz, V, Pinho e Melo, T, Brozman, M, Dvorak, M, Garay, R, Krastev, G, Kurca, E, Alvarez-Sabin, J, Chamorro, A, del Mar Freijo Guerrero, M, Herrero, Ja, Gil-Peralta, A, Leira, R, Martí-Vilalta, Jl, Masjuan Vallejo, J, Millán, M, Molina, C, Mostacero, E, Segura, T, Serena, J, Vivancos Mora, J, Danielsson, E, Cederin, B, Von, Zweigberg, Wahlgren, Ng, Welin, L, Lyrer, P, Bogousslavsky, J, Hungerbühler, Hj, Weder, B, Ford, Ga, Jenkinson, D, Macleod, Mj, Macwalter, Rs, Markus, Hs, Muir, Kw, Sharma, Ak, Walters, Mr, Warburton, Ea
Publikováno v:
New England journal of medicine, 359(13), 1317-1329. Massachussetts Medical Society
University of Helsinki
University of Helsinki
Background Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and safety when administered more than 3 hours after the onset of symptoms have not been established. We tested the efficacy
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.